ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2020-2-189-194ssmu-2876Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEW AND LECTURESНейровизуализационные методики оценки головного мозга при сахарном диабете (литературный обзор)Neuroimaging methods for assessing the brain in diabetes mellitus (literature review)https://orcid.org/0000-0001-9966-6686МатвееваМ. В.MatveevaM. V.matveeva.mariia@yandex.ruhttps://orcid.org/0000-0002-2667-4842СамойловаЮ. Г.SamoilovaYu. G.

д-р мед. наук, профессор, кафедра эндокринологии и диабетологии, зав. кафедрой детских болезней

Россия, 634050, г. Томск, Московский тракт, 2

https://orcid.org/0000-0001-6547-6622ЖуковаН. Г.ZhukovaN. G.https://orcid.org/0000-0002-2888-5539ТолмачевИ. В.TolmachovI. V.БразовскийК. С.BrazovskiyK. S.https://orcid.org/0000-0002-4340-5273ЛейманО. П.LeimanO. P.

аспирант, кафедра эндокринологии и диабетологии

Россия, 634050, г. Томск, Московский тракт, 2

https://orcid.org/0000-0002-6452-6584ФимушкинаН. Ю.FimushkinaN. Yu.ТонкихО. С.RotkankM. A.Сибирский государственный медицинский университет (СибГМУ)РоссияSiberian State Medical UniversityRussian Federation202012072020192189194Copyright © Матвеева М.В., Самойлова Ю.Г., Жукова Н.Г., Толмачев И.В., Бразовский К.С., Лейман О.П., Фимушкина Н.Ю., Тонких О.С., 20202020Матвеева М.В., Самойлова Ю.Г., Жукова Н.Г., Толмачев И.В., Бразовский К.С., Лейман О.П., Фимушкина Н.Ю., Тонких О.С.Matveeva M.V., Samoilova Y.G., Zhukova N.G., Tolmachov I.V., Brazovskiy K.S., Leiman O.P., Fimushkina N.Y., Rotkank M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/2876сахарный диабеткогнитивные нарушениянейровизуализационные методикиdiabetes mellituscognitive impairmentneuroimaging techniquesReferencesXia W., Chen Y., Luo Y., Zhang D., Chen H., Ma J., Yin X. Decreased spontaneous brain activity and functional connectivity in type 1 diabetic patients without microvascular complications. Cell Physiol. Biochem. 2018; 51 (6): 2694–2703. DOI: 10.1159/000495960.Xia W., Chen Y., Luo Y., Zhang D., Chen H., Ma J., Yin X. Decreased spontaneous brain activity and functional connectivity in type 1 diabetic patients without microvascular complications. Cell Physiol. Biochem. 2018; 51 (6): 2694–2703. DOI: 10.1159/000495960.McCall A.L. The impact of diabetes on the CNS. Diabetes. 1992; 41 (5): 557–570. DOI: 10.2337/diab.41.5.557.McCall A.L. The impact of diabetes on the CNS. Diabetes. 1992; 41 (5): 557–570. DOI: 10.2337/diab.41.5.557.Strachan M.W., Price J.F., Frier B.M. Diabetes, cognitive impairment, and dementia. BMJ. 2008; 336 (7634): 6. DOI: 10.1136/bmj.39386.664016.BE.Strachan M.W., Price J.F., Frier B.M. Diabetes, cognitive impairment, and dementia. BMJ. 2008; 336 (7634): 6. DOI: 10.1136/bmj.39386.664016.BE.Gohel M.G. Evaluation of glycemic control in patients with type 2 diabetes mellitus with and without microvascular complications International. Journal of Pharma and Bio Sciences. 2013; 4 (4): 794–802.Gohel M.G. Evaluation of glycemic control in patients with type 2 diabetes mellitus with and without microvascular complications International. Journal of Pharma and Bio Sciences. 2013; 4 (4): 794–802.Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008; 29 (4): 494–511. DOI: 10.1210/er.2007-0034.Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008; 29 (4): 494–511. DOI: 10.1210/er.2007-0034.Bangen K.J., Werhane M.L., Weigand A.J., Edmonds E.C., Delano-Wood L., Thomas K.R., Nation D.A., Evangelista N.D., Clark A.L., Liu T.T., Bondi M.W. Reduced regional cerebral blood flow relates to poorer cognition in older adults with type 2 diabetes. Front. Aging Neurosci. 2018; 10: 270. DOI: 10.3389/fnagi.2018.00270.Bangen K.J., Werhane M.L., Weigand A.J., Edmonds E.C., Delano-Wood L., Thomas K.R., Nation D.A., Evangelista N.D., Clark A.L., Liu T.T., Bondi M.W. Reduced regional cerebral blood flow relates to poorer cognition in older adults with type 2 diabetes. Front. Aging Neurosci. 2018; 10: 270. DOI: 10.3389/fnagi.2018.00270.Chen Y., Liu Z., Zhang J., Zhang J., Xu K., Zhang S., Wei D., Zhan Z. Altered brain activation patterns under different working memory loads in patients with type 2 diabetes. Diabetes Care. 2014; 37 (12): 3157–3163. DOI: 10.2337/dc14-1683.Chen Y., Liu Z., Zhang J., Zhang J., Xu K., Zhang S., Wei D., Zhan Z. Altered brain activation patterns under different working memory loads in patients with type 2 diabetes. Diabetes Care. 2014; 37 (12): 3157–3163. DOI: 10.2337/dc14-1683.Bertholdo D., Watcharakorn A., Castillo M. Brain proton magnetic resonance spectroscopy: introduction and overview. Neuroimaging Clin. N. Am. 2013; 23 (3): 359–380. DOI: 10.1016/j.nic.2012.10.002.Bertholdo D., Watcharakorn A., Castillo M. Brain proton magnetic resonance spectroscopy: introduction and overview. Neuroimaging Clin. N. Am. 2013; 23 (3): 359–380. DOI: 10.1016/j.nic.2012.10.002.Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54 (6): 1615–1625. DOI: 10.2337/diabetes.54.6.1615Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54 (6): 1615–1625. DOI: 10.2337/diabetes.54.6.1615Brands A.M., Biessels G.J., De Haan E.H., Kappelle L.J., Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005; 28 (3): 726–735. DOI: 10.2337/diacare.28.3.726.Brands A.M., Biessels G.J., De Haan E.H., Kappelle L.J., Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005; 28 (3): 726–735. DOI: 10.2337/diacare.28.3.726.Broadley M.M., White M.J., Andrew B. A systematic review and meta-analysis of executive function performance in type 1 diabetes mellitus. Psychosom. Med. 2017; 79 (6): 684–696. DOI: 10.1097/PSY.0000000000000460.Broadley M.M., White M.J., Andrew B. A systematic review and meta-analysis of executive function performance in type 1 diabetes mellitus. Psychosom. Med. 2017; 79 (6): 684–696. DOI: 10.1097/PSY.0000000000000460.Gaudieri P.A., Chen R., Greer T.F., Holmes C.S. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care. 2008; 31 (9): 1892–1897. DOI: 10.2337/dc07-2132.Gaudieri P.A., Chen R., Greer T.F., Holmes C.S. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care. 2008; 31 (9): 1892–1897. DOI: 10.2337/dc07-2132.Brands A.M., Kessels R.P., Hoogma R.P., Henselmans J.M., van der Beek Boter J.W., Kappelle L.J., de Haan E.H., Biessels G.J. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes. 2006; 55 (6): 1800–1806. DOI: 10.2337/db05-1226.Brands A.M., Kessels R.P., Hoogma R.P., Henselmans J.M., van der Beek Boter J.W., Kappelle L.J., de Haan E.H., Biessels G.J. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes. 2006; 55 (6): 1800–1806. DOI: 10.2337/db05-1226.Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Adler R.G., Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care. 1998; 21 (3): 379–384. DOI: 10.2337/diacare.21.3.379.Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Adler R.G., Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care. 1998; 21 (3): 379–384. DOI: 10.2337/diacare.21.3.379.Lyoo I.K., Yoon S., Renshaw P.F., Hwang J., Bae S., Musen G., Kim J.E., Bolo N., Jeong H.S., Simonson D.C. Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus. PLoS One. 2013; 8 (8): e71304. DOI: 10.1371/journal.pone.0071304.Lyoo I.K., Yoon S., Renshaw P.F., Hwang J., Bae S., Musen G., Kim J.E., Bolo N., Jeong H.S., Simonson D.C. Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus. PLoS One. 2013; 8 (8): e71304. DOI: 10.1371/journal.pone.0071304.Van Duinkerken E., Ijzerman R.G., Klein M., Moll A.C., Snoek F.J., Scheltens P., Pouwels P.J.W., Barkhof F., Diamant M., Tijms B.M. Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy. Hum. Brain Mapp. 2016; 37 (3): 1194–1208. DOI: 10.1002/hbm.23096.Van Duinkerken E., Ijzerman R.G., Klein M., Moll A.C., Snoek F.J., Scheltens P., Pouwels P.J.W., Barkhof F., Diamant M., Tijms B.M. Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy. Hum. Brain Mapp. 2016; 37 (3): 1194–1208. DOI: 10.1002/hbm.23096.Antenor-Dorsey J.A.V., Meyer E., Rutlin J., Perantie D.C., White N.H., Arbelaez A.M., Shimony J.S., Hershey T. White matter microstructural integrity in youth with type 1 diabetes. Diabetes. 2013; 62 (2): 581–589. DOI: 10.2337/db12-0696.Antenor-Dorsey J.A.V., Meyer E., Rutlin J., Perantie D.C., White N.H., Arbelaez A.M., Shimony J.S., Hershey T. White matter microstructural integrity in youth with type 1 diabetes. Diabetes. 2013; 62 (2): 581–589. DOI: 10.2337/db12-0696.Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006; 55 (2): 326–333. DOI: 10.2337/diabetes.55.02.06.db05-0520.Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006; 55 (2): 326–333. DOI: 10.2337/diabetes.55.02.06.db05-0520.Northam E.A., Rankins D., Lin A., Wellard R.M., Pell G.S., Finch S.J., Werther G.A., Cameron F.J. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Сare. 2009; 32 (2): 445–450. DOI: 10.2337/dc08-1657.Northam E.A., Rankins D., Lin A., Wellard R.M., Pell G.S., Finch S.J., Werther G.A., Cameron F.J. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Сare. 2009; 32 (2): 445–450. DOI: 10.2337/dc08-1657.Perantie D.C., Wu J., Koller J.M., Lim A., Warren S.L., Black K.J., Sadler M., White N.H., Hershey T. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007; 30 (9): 2331–2337. DOI: 10.2337/dc07-0351.Perantie D.C., Wu J., Koller J.M., Lim A., Warren S.L., Black K.J., Sadler M., White N.H., Hershey T. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007; 30 (9): 2331–2337. DOI: 10.2337/dc07-0351.Hershey T., Perantie D.C., Wu J., Weaver P.M., Black K.J., White N.H. Hippocampal volumes in youth with type 1 diabetes. Diabetes. 2010; 59 (1): 236–241.Hershey T., Perantie D.C., Wu J., Weaver P.M., Black K.J., White N.H. Hippocampal volumes in youth with type 1 diabetes. Diabetes. 2010; 59 (1): 236–241.DOI: 10.2337/db09-1117.DOI: 10.2337/db09-1117.Marzelli M.J., Mazaika P.K., Barnea-Goraly N., Hershey T., Tsalikian E., Tamborlane W., Mauras N., White N.H., Buckingham B., Beck R.W., Ruedy K.J., Kollman C., Cheng P., Reiss A.L. Diabetes research in children network (DirecNet).Marzelli M.J., Mazaika P.K., Barnea-Goraly N., Hershey T., Tsalikian E., Tamborlane W., Mauras N., White N.H., Buckingham B., Beck R.W., Ruedy K.J., Kollman C., Cheng P., Reiss A.L. Diabetes research in children network (DirecNet).Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes. 2014; 63 (1): 343–353. DOI: 10.2337/db13-0179.Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes. 2014; 63 (1): 343–353. DOI: 10.2337/db13-0179.Kodl C.T., Franc D.T., Rao J.P., Anderson F.S., Thomas W., Mueller B.A., Lim K.O., Seaquist E.R. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008; 57 (1): 3083–3089. DOI: 10.2337/db08-0724.Kodl C.T., Franc D.T., Rao J.P., Anderson F.S., Thomas W., Mueller B.A., Lim K.O., Seaquist E.R. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008; 57 (1): 3083–3089. DOI: 10.2337/db08-0724.Van Duinkerken E., Schoonheim M.M., Sanz-Arigita E.J., IJzerman R.G., Moll A.C., Snoek F.J., Ryan C.M., Klein M., Diamant M., Barkhof F. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes. 2012; 61: 1814–1821. DOI: 10.2337/db11-1358.Van Duinkerken E., Schoonheim M.M., Sanz-Arigita E.J., IJzerman R.G., Moll A.C., Snoek F.J., Ryan C.M., Klein M., Diamant M., Barkhof F. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes. 2012; 61: 1814–1821. DOI: 10.2337/db11-1358.Van Duinkerken E., Ryan C.M., Schoonheim M.M., Barkhof F., Klein M., Moll A.C., Diamant M., Ijzerman R.G., Snoek F.J. Subgenual cingulate cortex functional connectivity in relation to depressive symptoms and cognitive functioning in type 1 diabetes mellitus patients. Psychosom. Med. 2016; 78: 740–749.Van Duinkerken E., Ryan C.M., Schoonheim M.M., Barkhof F., Klein M., Moll A.C., Diamant M., Ijzerman R.G., Snoek F.J. Subgenual cingulate cortex functional connectivity in relation to depressive symptoms and cognitive functioning in type 1 diabetes mellitus patients. Psychosom. Med. 2016; 78: 740–749.Ryan J.P., Aizenstein H.J., Orchard T.J., Ryan C.M., Saxton J.A., Fine D.F., Nunley K.A., Rosano C. Age of childhood onset in type 1 diabetes and functional brain connectivity in midlife. Psychosom. Med. 2015; 77: 622.Ryan J.P., Aizenstein H.J., Orchard T.J., Ryan C.M., Saxton J.A., Fine D.F., Nunley K.A., Rosano C. Age of childhood onset in type 1 diabetes and functional brain connectivity in midlife. Psychosom. Med. 2015; 77: 622.Van Duinkerken E., Schoonheim M.M., IJzerman R.G., Moll A.C., Landeira-Fernandez J., Klein M., Diamant M., Snoek F.J., Barkhof F,. Wink A.-M. Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus. Hum. Brain Mapp. 2017; 38: 3623–3636.Van Duinkerken E., Schoonheim M.M., IJzerman R.G., Moll A.C., Landeira-Fernandez J., Klein M., Diamant M., Snoek F.J., Barkhof F,. Wink A.-M. Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus. Hum. Brain Mapp. 2017; 38: 3623–3636.Demuru M., van Duinkerken E., Fraschini M., Marrosu F., Snoek F.J., Barkhof F., Klein M., Diamant M., Hillebrand A. Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients. Neuroimage Clin. 2014; 5: 69–76.Demuru M., van Duinkerken E., Fraschini M., Marrosu F., Snoek F.J., Barkhof F., Klein M., Diamant M., Hillebrand A. Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients. Neuroimage Clin. 2014; 5: 69–76.Mangia S., Kumar A.F., Moheet A.A., Roberts R.J., Eberly L.E., Seaquist E.R., Tkáč I. Neurochemical profile of patients with type 1 diabetes measured by (1)H-MRS at 4 T. J. Cereb. Blood Flow Metab. 2013; 33: 754–759. DOI: 10.1038/jcbfm.2013.13.Mangia S., Kumar A.F., Moheet A.A., Roberts R.J., Eberly L.E., Seaquist E.R., Tkáč I. Neurochemical profile of patients with type 1 diabetes measured by (1)H-MRS at 4 T. J. Cereb. Blood Flow Metab. 2013; 33: 754–759. DOI: 10.1038/jcbfm.2013.13.Heikkila O., Lundbom N., Timonen M., Groop P.H., Heikkinen S., Makimattila S. Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia. 2009; 52: 534–540. DOI: 10.1007/s00125-008-1242-2.Heikkila O., Lundbom N., Timonen M., Groop P.H., Heikkinen S., Makimattila S. Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia. 2009; 52: 534–540. DOI: 10.1007/s00125-008-1242-2.Seaquist E.R., Tkac I., Damberg G., Thomas W., Gruetter R. Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism. 2005; 54: 1008–1013. DOI: 10.1016/j.metabol.2005.02.018.Seaquist E.R., Tkac I., Damberg G., Thomas W., Gruetter R. Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism. 2005; 54: 1008–1013. DOI: 10.1016/j.metabol.2005.02.018.Sarac K., Akinci A., Alkan A., Aslan M., Baysal T., Ozcan C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology. 2005; 47: 562–565. DOI: 10.1007/s00234-005-1387-3.Sarac K., Akinci A., Alkan A., Aslan M., Baysal T., Ozcan C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology. 2005; 47: 562–565. DOI: 10.1007/s00234-005-1387-3.Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5 (1): 64–74.Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5 (1): 64–74.Exalto L.G., Whitmer R.A., Kappele L.J., Biessels G.J. An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp. Gerontol. 2012; 47 (11): 858–864.Exalto L.G., Whitmer R.A., Kappele L.J., Biessels G.J. An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp. Gerontol. 2012; 47 (11): 858–864.Yates K.F., Sweat V., Yau P.L., Turchiano M.M., Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 2012; 32 (9): 2060–2067.Yates K.F., Sweat V., Yau P.L., Turchiano M.M., Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 2012; 32 (9): 2060–2067.Geijselaers S.L.C., Sep S.J.S., Stehouwer C.D.A., Biessels G.J. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. 2015; 3 (1): 75–89. DOI: 10.1016/S2213-8587(14)70148-2. Epub 2014 Aug 24.Geijselaers S.L.C., Sep S.J.S., Stehouwer C.D.A., Biessels G.J. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. 2015; 3 (1): 75–89. DOI: 10.1016/S2213-8587(14)70148-2. Epub 2014 Aug 24.Van Harten B., deLeeuw F.E., Weinstein H.C., Scheltens P., Biessels G.J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006; 29: 2539–2548.Van Harten B., deLeeuw F.E., Weinstein H.C., Scheltens P., Biessels G.J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006; 29: 2539–2548.De Bresser J., Tiehuis A.M., van den Berg E., Reijmer Y.D., Jongen C., Kappelle L.J., Mali W.P., Viergever M.A., Biessels G.J. On behalf of the Utrecht Diabetic Encephalopathy Study Group. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care. 2010; 33: 1309–1314.De Bresser J., Tiehuis A.M., van den Berg E., Reijmer Y.D., Jongen C., Kappelle L.J., Mali W.P., Viergever M.A., Biessels G.J. On behalf of the Utrecht Diabetic Encephalopathy Study Group. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care. 2010; 33: 1309–1314.Kooistra M., Geerlings M.I., Mali W.P., Vincken K.L., van der Graaf Y., Biessels G.J. SMART-MR Study Group. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR Study. J. Neurol. Sci. 2013; 332: 69–74. DOI: 10.1016/j.jns.2013.06.019.Kooistra M., Geerlings M.I., Mali W.P., Vincken K.L., van der Graaf Y., Biessels G.J. SMART-MR Study Group. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR Study. J. Neurol. Sci. 2013; 332: 69–74. DOI: 10.1016/j.jns.2013.06.019.Musen G., Jacobson A.M., Bolo N.R., Simonson D.C., Shenton M.E., McCartney R.L., Flores V.L., Hoogenboom W.S. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012; 61: 2375–2379. DOI: 10.2337/db11-1669.Musen G., Jacobson A.M., Bolo N.R., Simonson D.C., Shenton M.E., McCartney R.L., Flores V.L., Hoogenboom W.S. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012; 61: 2375–2379. DOI: 10.2337/db11-1669.Sinha S., Ekka M., Sharma U., Pandey R.M., Jagannathan N.R. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res. 2014; 7: 41. DOI: 10.1186/1756-0500-7-41.Sinha S., Ekka M., Sharma U., Pandey R.M., Jagannathan N.R. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res. 2014; 7: 41. DOI: 10.1186/1756-0500-7-41.Sahin I., Alkan A., Keskin L., Cikim A., Karakas H.M., Firat A.K., Sigirci A. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complications. 2008; 22 (4): 254–260. DOI: 10.1016/j.jdiacomp.2007.03.007.Sahin I., Alkan A., Keskin L., Cikim A., Karakas H.M., Firat A.K., Sigirci A. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complications. 2008; 22 (4): 254–260. DOI: 10.1016/j.jdiacomp.2007.03.007.Groeneveld O., Reijmer Y., Heinen R., Kuijf H., Koekkoek P., Janssen J., Rutten G., Kappelle L., Biessels G. Cog-Id Study Group. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2018; 28 (12): 1253–1260. DOI: 10.1016/j.numecd.2018.07.008.Groeneveld O., Reijmer Y., Heinen R., Kuijf H., Koekkoek P., Janssen J., Rutten G., Kappelle L., Biessels G. Cog-Id Study Group. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2018; 28 (12): 1253–1260. DOI: 10.1016/j.numecd.2018.07.008.Macpherson H., Formica M., Harris E., Daly R.M. Brain functional alterations in type 2 diabetes – a systematic review of fMRI studies. Front. Neuroendocrinol. 2017; 47: 34–46. DOI: 10.1016/j.yfrne.2017.07.001.Macpherson H., Formica M., Harris E., Daly R.M. Brain functional alterations in type 2 diabetes – a systematic review of fMRI studies. Front. Neuroendocrinol. 2017; 47: 34–46. DOI: 10.1016/j.yfrne.2017.07.001.Rae C.D. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem. Res. 2014; 39 (1): 1–36. DOI: 10.1007/s11064-013-1199-5.Rae C.D. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem. Res. 2014; 39 (1): 1–36. DOI: 10.1007/s11064-013-1199-5.Gujar S.K., Maheshwari S., Björkman-Burtscher I., Sundgren P.C. Magnetic resonance spectroscopy. J. Neuroophthalmol. 2005; 25 (3): 217–226. DOI: 10.1097/01.wno.0000177307.21081.81.Gujar S.K., Maheshwari S., Björkman-Burtscher I., Sundgren P.C. Magnetic resonance spectroscopy. J. Neuroophthalmol. 2005; 25 (3): 217–226. DOI: 10.1097/01.wno.0000177307.21081.81.Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat. Rec. 2001; 265 (2): 54–84. DOI: 10.1002/ar.1058.Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat. Rec. 2001; 265 (2): 54–84. DOI: 10.1002/ar.1058.

The authors declare that there are no conflicts of interest present.